Amgen settles with FTC over US$28 billion deal
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Robots make it to the healthcare conference panel, reflecting the future potential of technology
KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population
Aims to build the largest connected healthcare ecosystem in India
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
SKYSCRAPER-01 is ongoing and the study remains blinded to patients and investigators
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Subscribe To Our Newsletter & Stay Updated